Home > Insider Trading > Filing (0000899243-20-023202)

Filing Details

Accession Number:: 0000899243-20-023202
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-08-21 16:25:03
Reporting Period:: 2020-08-19

Accepted Time:: 2020-08-21 16:25:03
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1054721	Bsquare Corp	BSQR	Services-Business Services, Nec (7389)	911650880

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1387846	Palogic Value Fund, Lp	5310 Harvest Hill Road, Suite 110 Dallas TX 75230	No	No	No	Yes
1494018	Palogic Capital Management, Llc	5310 Harvest Hill Road, Suite 110 Dallas TX 75230	No	No	No	Yes
1532943	Palogic Value Management, L.p.	5310 Harvest Hill Road, Suite 110 Dallas TX 75230	No	No	No	Yes
1574629	L. Ryan Vardeman	5310 Harvest Hill Road, Suite 110 Dallas TX 75230	Yes	No	No	Yes

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, No Par Value	Acquisiton	2020-08-19	25,112	$1.34	1,560,823	No	4	P	Indirect	See footnotes
Common Stock, No Par Value	Acquisiton	2020-08-20	3,773	$1.35	1,564,596	No	4	P	Indirect	See footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See footnotes
No	4	P	Indirect	See footnotes

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, No Par Value	85,173	Direct

Footnotes

This price represents the approximate weighted average price per share of common stock of BSQUARE Corporation, a Washington corporation (the "Issuer"), no par value ("Shares"), of purchases that were executed at prices ranging from $1.33 to $1.35 per Share. The reporting persons undertake to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the price per Share and the number of Shares purchased at each price.
This statement is jointly filed by and on behalf of each of Ryan L. Vardeman, Palogic Value Fund, L.P., a Delaware limited partnership ("Palogic Value Fund"), Palogic Value Management, L.P., a Delaware limited partnership ("Palogic Value Management"), and Palogic Capital Management, LLC, a Delaware limited liability company ("Palogic Capital Management"). Mr. Vardeman and Palogic Value Fund are the record and direct beneficial owners of the securities covered by this statement. Palogic Value Management is the general partner of, and may be deemed to beneficially own securities owned by, Palogic Value Fund.
(Continued from Footnote 2) Palogic Capital Management is the general partner of, and may be deemed to beneficially own securities beneficially owned by, Palogic Value Management. Mr. Vardeman is the sole member of, andmay be deemed to beneficially own securities beneficially owned by, Palogic Capital Management. Mr. Vardeman is also a limited partner in, and may be deemed to beneficially own securities owned by, Palogic Value Fund.
The reporting persons state that neither the filing of this statement nor anything herein shall be deemed an admission that the reporting persons are, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise, the beneficial owners of any securities covered by this statement. The reporting persons disclaim beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of the reporting persons in such securities.
The reporting persons may be deemed to be a member of a group with respect to the Issuer or securities of the Issuer for purposes of Section 13(d) or 13(g) of the Exchange Act. The reporting persons declare that neither the filing of this statement nor anything herein shall be construed as an admission that such persons are, for the purposes of Section 13(d) or 13(g) of the Exchange Act or any other purpose, a member of a group with respect to the Issuer or securities of the Issuer.
This price represents the approximate weighted average price per Share of purchases that were executed at prices ranging from $1.34 to $1.35 per Share. The reporting persons undertake to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the price per Share and the number of Shares purchased at each price.
Includes 33,784 restricted stock units of the Issuer awarded to Mr. Vardeman on July 17, 2020, pursuant to the Issuer's compensation plan for non-employee directors and the Fourth Amended and Restated Stock Plan of the Issuer which have not yet vested.